Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States
figureposted on 2020-03-11, 12:39 authored by Camilo Obando, Zhijie Ding, Erik Muser, Neel Vaidya, Wenqin Qiang, Xiaoxi Sun, Huiqi Wang, Rajesh Mallampati, Lin Xie
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.